TrialCardiovascular diabetology2024

Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial.

Ana Ojeda-Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.